MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    VPS13A Disease: 15 Years of Illness Awaiting a Diagnosis

    K. Manysheva, D. Makhmudova (Makhachkala, Russian Federation)

    Objective: Objective. Diagnosing a disease with movement disorders is not always easy. It is even more difficult when there is a family history of hereditary…
  • 2026 International Congress

    Paroxismal Torticollis Revealing Cervical disc Calcifications in a Child About a Case

    C. Boukadir (Benaknoun; Algiers, Algeria)

    Objective: Cervical dystonia in children is rare compared to adults (1), and is often of sequelae or genetic origin (1). The objective of our work…
  • 2026 International Congress

    Disabling Holmes Tremor Following Pontine Hemorrhage Accompanied by a Unique Constellation of Movement Disorders

    P. Cataniag, J. Cruz, J. Ong, C. Diesta, J. Oropilla, R. Teleg, K. Amamanglon, M. Mendoza (Makati City, Philippines)

    Objective: To report a case of an adult Filipino male who developed delayed complex post-stroke movement disorders following a pontine hemorrhage. Background: Holmes tremor (HT)…
  • 2026 International Congress

    Underestimation of Nighttime Sleep Symptoms in Isolated RBD is Associated with Increased Risk of Phenoconversion to Synucleinopathy: A North American Prodromal Synucleinopathy Consortium Study

    J. Ha, D. Bliwise, H. Dela Cruz, C. Xiong, T. Ferman, K. Kantarci, V. Lowe, S. Criswell, E. ST. Louis, D. Huddleston, A. Avidan, Y. Ju, M. Lim, M. Miglis, R. Postuma, A. Videnovic, B. Boeve, M. Howell, L. Trotti (Atlanta, USA)

    Objective: To determine whether mismatch between participant (PT) self-perceived and bed partner (BP)–reported sleep symptoms is associated with risk of phenoconversion to synucleinopathy. Background: Patients…
  • 2026 International Congress

    Effects of Immersive Gamification Technology on the Physical Function of People with Parkinson’s Disease: A Scoping Review

    KI. Guitones, ME. Aguila (Manila, Philippines)

    Objective: This scoping review serves to provide an overview of the methods and effects of different ImGTS on various aspects of physical function (e.g., balance,…
  • 2026 International Congress

    Clinical Profile and Key Correlates of Genetic Load, Motor Severity, and Caregiver Burden in an Iranian Huntington’s Disease Cohort

    M. Salari, K. Rezaei, M. Etemadifar (Tehran, Islamic Republic of Iran)

    Objective: To characterize an Iranian Huntington’s disease (HD) cohort and quantify associations between CAG repeat length, age at onset, motor severity, and caregiver burden. Background:…
  • 2026 International Congress

    Cognitive Profile In Indian Patients with Spinocerebellar Ataxia (SCA) – Prospective Cross-sectional Study

    A. Patel, M. Bhatt, A. Aggarwal (Mumbai, India)

    Objective: To evaluate the prevalence, spectrum, and severity of cognitive impairment in Indian patients with genetically confirmed SCA and corelate with motor severity. Background: Beyond…
  • 2026 International Congress

    Comparative Motor Response to Bilateral STN‑DBS in LRRK2‑Related and Idiopathic Parkinson’s Disease

    J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To compare motor improvement after subthalamic nucleus deep brain stimulation (STN‑DBS) in patients with LRRK2‑associated Parkinson’s disease (PD) versus idiopathic PD (iPD). Background: LRRK2…
  • 2026 International Congress

    Clinical and Autonomic Correlates of Chronic Sialorrhea in Parkinson’s Disease: A Questionnaire-Based Study with Cluster Analysis of Autonomic and Dysphagia Burden

    S. Okusa, R. Okochi, Y. Sakai, T. Nukariya, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: To examine factors associated with drooling in patients with Parkinson’s disease (PD), patient awareness and perceptions of botulinum toxin therapy, and the relative contributions…
  • 2026 International Congress

    Single centre experience with subcutaneous foslevodopa/foscarbidopa for GBA Parkinson’s disease

    I. Muro, E. Casas, P. Lorenzo-Barreto, B. González, L. López-Manzanares (Madrid, Spain)

    Objective: To describe the clinical outcomes of two patients with GBA Parkinson’s disease (GBA-PD) and severe motor fluctuations treated with subcutaneous foslevodopa/foscarbidopa (fld/fcd) infusion. Background:…
  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley